Apidra Solostar 100IU/ml Injection

Apidra Solostar 100IU/ml Injection 3 ml is rapid-acting insulin for the treatment of diabetes mellitus in both children (above six years of age) and adults. The active ingredient in Apidra Solostar 100IU/ml Injection 3 ml is insulin glulisine. Apidra Solostar 100IU/ml Injection 3 ml is a recombinant human insulin analogue that is equipotent to regular human insulin. Insulin glulisine has a more rapid onset of action and a shorter duration of action than regular human insulin. Diabetes is a lifelong condition that causes a person’s blood sugar level to become too high.

Apidra Solostar 100IU/ml Injection 3 ml is a fast-acting insulin that works rapidly to normalise blood sugar levels after a meal. It typically begins working within 10-20 minutes after injection, peaks in about 1 hour, and keeps working for 2 to 4 hours. Due to this short action, Apidra Solostar 100IU/ml Injection 3 ml should normally be taken in combination with intermediate-acting or long-acting insulin preparations. Apidra Solostar 100IU/ml Injection 3 ml works by ensuring rapid and consistent sugar control. Apidra Solostar 100IU/ml Injection 3 ml is a fast-acting form of insulin that helps lower blood sugar levels after food intake. Prevents the risk of having severe complications of diabetes.

The primary role of insulin and insulin analogues, including insulin glulisine, is glucose metabolism control. Insulin lowers blood glucose levels by stimulating peripheral glucose uptake, particularly skeletal muscle and fat, and inhibiting hepatic glucose production. Insulin glulisine takes effect about twice as fast as regular human insulin and completes the glucose-lowering effect about 2 hours earlier than regular human insulin.